July 14th, 2021– Poseida joins Cellares’ early-access cell therapy tech program
July 14, 2021
BioProcess International
Related News
-
September 12, 2024Cellares and Sony Announce a Joint Development Collaboration to Integrate Flow Cytometry-Based Sorting and Online Analysis into an Automated, High-Throughput Cell Therapy Manufacturing Platform
-
September 05, 2024
Cellares Announces Completion of First cGMP Cell Shuttle at IDMO Smart Factory in Bridgewater, New Jersey
-
September 03, 2024
Cellares Appoints Justin McAnear as CFO and Jonathan Butler as General Counsel
